News
The CDC is considering recommending annual COVID-19 shots to those who are older or who have compromised immune function, ...
At its first meeting under the new administration, the US Centers for Disease Control and Prevention’s (CDC) Advisory ...
Penmenvy combines the antigenic components of Bexsero (meningococcal Group B vaccine) and Menveo (meningococcal Groups A, C, Y, and W-135 oligosaccharide diphtheria CRM197 conjugate vaccine).
The updated recommendations are pending final approval by the director of the CDC and the Department of Health and Human Services.
Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that during its regular meeting on April 16, the U.S. Centers for Disease Control and Prevention’s (CDC) ...
The Advisory Committee on Immunization Practices voted Wednesday to recommend lowering the age at which adults can get a ...
The US Centers for Disease Control and Prevention's outside panel of vaccine experts this week discussed narrowing ...
A key vaccine advisory committee is meeting for the first time under new U.S. Health Secretary Robert F. Kennedy Jr., a ...
THURSDAY, April 17, 2025 (HealthDay News) — A panel of federal health experts on Wednesday recommended expanded vaccine ...
RSV vaccines could get broader CDC backing for adults aged 50-59 at risk after an endorsement from an agency's expert panel. Read more here.
The pharmaceutical company said Thursday that the U.S. Advisory Committee on Immunization Practices had issued a positive recommendation on GSK's 5-in-1 meningitis vaccine Penmenvy as well as its ...
Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results